N-Cadherin Antikörper (Cytoplasmic Domain)
-
- Target Alle N-Cadherin (CDH2) Antikörper anzeigen
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
-
Bindungsspezifität
- Cytoplasmic Domain
-
Reaktivität
- Human, Ratte
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser N-Cadherin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Ratte (Rattus)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Recombinant MBP fusion protein containing the entire cytoplasmic domain of human N-cadherin.
- Klon
- 13A9
- Isotyp
- IgG1
- Top Product
- Discover our top product CDH2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane." in: The Journal of biological chemistry, Vol. 278, Issue 19, pp. 17269-76, (2003) (PubMed).
: "Developmental expression and distribution of N- and E-cadherin in the rat ovary." in: Biology of reproduction, Vol. 63, Issue 3, pp. 797-804, (2000) (PubMed).
: "
-
N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane." in: The Journal of biological chemistry, Vol. 278, Issue 19, pp. 17269-76, (2003) (PubMed).
-
- Target
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
- Andere Bezeichnung
- N-CADHERIN (CDH2 Produkte)
- Hintergrund
- Synonyms: CD325
- Gen-ID
- 1000, 83501
- UniProt
- P19022, Q9Z1Y3
- Pathways
- Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
-